DLHHCOP’S JOURNAL OF PHARMACEUTICAL RESEARCH
Instructions to Author
|Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. The publisher will presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to Journal. Submission of an article to journal is understood to imply that it has not been either published or not being considered for publication elsewhere. |
Manuscripts will be reviewed by members of the editorial board, whose opinions will form the basis of the final decision by the editor. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission. Failure to follow them may result in papers being delayed or rejected.
Types of manuscripts
Research papers should contain unpublished results of original research, which must be presented in sufficient detail to ensure the reproducibility of the described experiments and should present new experimental studies in elaborate form that constitute a significant contribution to knowledge. Research Papers should not exceed 18 pages.
Short communications are the one that should present new important findings in brief, a maximum of 9 pages including illustrations.
All manuscripts are reviewed by the editors, members of the editorial board, or qualified reviewers / experts through double blind peer review process. When a manuscript is submitted to the journal, it is given a number and assigned to two reviewers. The reviewers operate under strict guidelines and are expected complete their reviews quickly. After receipt of reviewers report, the corresponding author will be notified of the editor’s decision to accept without change, recommended for modification, further review, or reject. When modifications are requested, the corresponding author must either submit the modified version within 2 days or withdraw the manuscript. Manuscripts that have been rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided in the appropriate field on the submission form.
Each manuscript should be neatly typed, single-spaced throughout; including tables, graphs, figures. Manuscript should be uniform size with at least 2.54cm margin on all sides.
Prepare the manuscript in Times New Roman font using a font size of 12. Title shall be in a font size 14, bold face capitals. All section titles in the manuscript shall be in font size 12, bold face capitals. Subtitles in each section shall be in font size 12, bold face lower case. Standard International Units could be used throughout the text.
Pages should not be numbered, manuscript should be starting with the title page and the text should be arranged in the following order:
1) Title Page
3) Key words
5) Materials and Methods
6) Results and Discussion
8) Conflict of interest, if any
11) Tables and Figures
The title should be clear, concise and informative followed by the names and affiliations of the authors. Each author must provide their full name including their forenames and surname. The affiliation should comprise the department, institution (usually university or company), city, and state (or nation). The Corresponding Author of the manuscript must be marked with an asterisk* and should be listed first. In addition, the corresponding author must indicate his or her complete mailing address, office/cellular phone number, fax number and email address at the lower left of the title page.
Abstract and keywords
Materials and Methods
The section Materials and Methods should include concise details on the methodology adopted, sufficient to repeat the experiment. Please provide concise but complete information about the material and the analytical, statistical and experimental procedures used. Extracts and/or fractions tested for in vitro or in vivo biological activities should be chemically defined, at least by means of the results of preliminary phytochemical screening. Complete formulation details of all crude drug mixtures and extracts should be mentioned. The plant name should be fully mentioned when cited first, and the authors are asked to add the details regarding its identification, voucher herbarium specimen number and name of the herbarium institution where it has been deposited. The statistical method and the level of significance chosen should be clearly stated. In case of animal experiments authors must give the details of ethical approval.
Results and Discussion
Data acquired from the research with appropriate statistical analysis described in the methods section should be included in this section. All results presented in tabular or graphical form shall be described in this section. Should contain a critical review of the results of the study with the support of relevant literature. Discussion should relate the results to current understanding of the scientific problems being investigated in the field.
number is more than two use et al after the names of two authors)
Example: Pawar HA, Dhavale R. Development and evaluation of gastroretentive floating tablets of an antidepressant drug by
Thermoplastic granulation technique. Beni-suef university journal of basic and applied sciences. 2014; 3(2):122-32.
Example: Pawar HA, A Test Book of Quality Assurance, First edition, Everest Publishing House, Pune, 2019, 21.
Should be about 18 pages long, contain up-to-date information, comprehensively cover relevant literature and preferably be written by scientists who have in-depth knowledge on the topic. All format requirements are same as those applicable to full papers. Review articles need not be divided into sections such as Materials and Methods and Results and Discussion, but should definitely have an Abstract and Introduction, if necessary.
Authors publishing results from in vivo experiments involving animals or humans should state whether due permission for conduction of these experiments was obtained, from the relevant ethics committees, in the Materials and Methods section. In addition, authors wishing to publish research work involving human studies should also send a notary verified letter of approval from the Ethics Committee or the Institutional Review Board.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Statement of Informed Consent
All papers submitted to our Journal should declare agreement with the following ‘statement of informed consent’. No paper lacking it, will be considered for publication. Patients have a right to privacy that should not be infringed without informed consent. All information which could contribute to identify patients, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, etc., unless the information is essential for scientific purposes and the patient (or parent or guardian) gives explicit written informed consent for publication. For this purpose, the manuscript should be shown to the patient before publication and specific and explicit informed consent should be obtained. Furthermore, individuals who provide writing assistance should be identified by the authors, and they must disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. However, since complete anonymity is difficult to achieve, informed consent should be obtained from each patient involved, if there is any doubt. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning, and editors will note that.
Statement of Human and Animal Rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
Statement of Conflict of Interest
The authors whose names is mentioned in the manuscript certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Copyright and Permission
Submission is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere. Authors would be required to sign a form transferring copyright before the manuscript can be published.
Manuscript can be submitted along with a scanned copy of duly signed copy right form by mailing at following Email ID: firstname.lastname@example.org
Proofs will be sent to the corresponding author by PDF for final proof reading and appropriate corrections and should be returned via email within 48 hours of receipt. No additions and revisions are allowed other than the correction of typographical errors.
|Authors are requested to send their manuscripts strictly according to the given format mentioned in the guidelines to the authors.|